TP53 and neoplasm: More interestingly, the SIC of actinomycin D specifically stimulated a p53-dependant transcription factor, which enhanced its killing power of p53 human tumor cells [34], and also prevented the Coxsackie B3 virus and HIV-1 [12,13], making actinomycin D one of the most talented candidates for medicinal development purposes [35].